Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Veradermics, Inc.(MANE) | 2,401,868 | 2,401,868 | 0 | 151,678 | 295,286 | 28.42% | +143,608 |
| Avalyn Pharma, Inc | 0 | 3,308,649 | +3,308,649 | 0 | 108,921 | 10.48% | +108,921 |
| Odyssey Therapeutics, Inc. | 0 | 3,794,883 | +3,794,883 | 0 | 71,002 | 6.83% | +71,002 |
| Zenas BioPharma, Inc(ZBIO) | 5,037,854 | 5,037,854 | 0 | 98,490 | 127,861 | 12.31% | +29,371 |
| Mobia Medical, Inc | 0 | 1,986,072 | +1,986,072 | 0 | 26,613 | 2.56% | +26,613 |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | 69,442 | 94,438 | 9.09% | +24,996 |
| CRISPR Therapeutics AG(CRSP) | 2,038,763 | 2,038,763 | 0 | 96,984 | 111,194 | 10.70% | +14,210 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 43,177 | 55,151 | 5.31% | +11,975 |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | 7,033 | 9,433 | 0.91% | +2,400 |
| Ultragenyx Pharmaceutical Inc.(RARE) | 137,753 | 137,753 | 0 | 2,886 | 4,600 | 0.44% | +1,714 |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | 32,224 | 32,143 | 3.09% | -80 |
| Mineralys Therapeutics Inc.(MLYS) | 1,563,966 | 1,563,966 | 0 | 42,368 | 42,196 | 4.06% | -172 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 5,092 | 1,294 | 0.12% | -3,799 |
| Oculis Holding AG(OCS) | 641,022 | 641,022 | 0 | 17,045 | 8,891 | 0.86% | -8,154 |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,615,384 | +100,455 | 58,477 | 49,985 | 4.81% | -8,492 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 0 | -430,330 | 21,108 | 0 | — | -21,108 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 0 | -2,346,630 | 269,440 | 0 | — | -269,440 |